CURIS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CURIS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $1.00K, a 99.95% decline year-over-year.
- CURIS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $1.80M.
- CURIS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $77.00K, a 1.28% decline year-over-year.
- CURIS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $2.22M.
- CURIS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $77.00K, a 45.39% decline from fiscal 2024.
- CURIS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $141.00K, a 53.31% decline from fiscal 2023.
- CURIS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $302.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $1.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $77.00K 10-K · filed 2026-03-24 | |
| 2025-09-30 | $1.80M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $77.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $2.22M 10-Q · filed 2025-11-06 | |
| 2024-12-31 | $141.00K 10-K · filed 2026-03-24 | |
| 2024-06-30 | $78.00K 10-Q · filed 2024-11-14 | |
| 2023-12-31 | $302.00K 10-K · filed 2025-03-31 | |
| 2023-06-30 | $178.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $8.00K 10-Q · filed 2024-11-14 | |
| 2020-06-30 | $29.00K 10-Q · filed 2021-11-09 | |
| 2019-06-30 | $42.00K 10-Q · filed 2020-11-10 | |
| 2018-09-30 | $895.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $112.00K 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |